Roche Shows New Research-And-Development Approach Is Bearing Fruit — Market Talk

Roche Holding's clinical-trial success rate has improved and research-and-development cycles shortened since the company introduced a more stringent approach to its drug pipeline after a series of failed studies in 2022, Vontobel's Stefan Schneider says. The Swiss drugmaker used an event with inves…